June 12, 2015 - Researchers announce the results of an early study that shows a fused fluoroscopic/ echocardiographic imaging (FFEI) system is feasible and provides improved guidance of interventional procedures in pediatric patients with congenital heart disease. An estimated 40,000 children are born in the United States each year with various forms of Congenital Heart Disease, with at least a quarter of those requiring some type of surgical intervention. The study is being presented at the 2015 American Society of Echocardiography (ASE) June 12- 16, in Boston.

While FFEI systems have been used in adult patients undergoing various cardiac procedures, its use has not been widely explored during catheterization procedures in pediatric patients.  In this study, the FFEI system was successfully used in 25 patients with congenital heart disease from January 2013 to January 2015. Twenty out of 25 procedures were graded as superior (80%) and none were graded as inferior. "These results show that procedural guidance using FFEI systems in congenital heart disease is not only feasible, but it also provides improved guidance over the current standard of care," noted Primary Investigator Pei-Ni Jone, M.D., of Children's Hospital Colorado. 

"Future studies might explore whether the FFEI system could decrease exposure to radiation with decreased use of fluoroscopy, which would be an important additional benefit in such a young population," Jone concluded.
 
Researchers on the study, "Procedural Guidance Using a Fused Fluoroscopic/Three Dimensional Echocardiography Imaging System in Congenital Heart Disease," include Pei-Ni Jone, Michael DiMaria, and Thomas Fagan from the University of Colorado School of Medicine in Aurora, Colo.; and John Bracken of Philips Research North America in Briarcliff Manor, N.Y.
 
Jone will present a poster based on this research Monday, June 15, 2015, during ASE at the Hynes Convention Center in Boston, Mass. 
 
For more information: www.asescientificsessions.org
 

Related Content

News | Magnetic Resonance Imaging (MRI)

Jan. 27, 2026 — Hyperfine has announced results from the largest data set to date evaluating stroke detection with its ...

Time January 28, 2026
arrow
News | PET Imaging

Jan. 26, 2026 — Nuclidium, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...

Time January 27, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Jan. 20, 2026 — Hyperfine, the developer of the first FDA-cleared AI-powered portable MRI system for the brain — the ...

Time January 20, 2026
arrow
News | Cardiac Imaging

Dec. 15, 2025 — Royal Philips has entered into an agreement to acquire SpectraWAVE, Inc., an innovator in enhanced ...

Time December 18, 2025
arrow
News | Computed Tomography (CT)

Sept. 29, 2025 — Many studies have shown the inverse relationship between bone mineral density (BMD) — the gold standard ...

Time September 30, 2025
arrow
News | Focused Ultrasound Therapy

Aug. 26, 2025 — In a quest for ever-more-effective treatments for pancreatic cancer, HonorHealth Research Institute is ...

Time August 29, 2025
arrow
News | Innovative Hospitals

Aug. 14, 2025 — An interventional radiologist at NYU Langone Health recently performed a procedure to relieve a patient ...

Time August 14, 2025
arrow
News | Breast Imaging

July 7, 2025 — SimonMed Imaging, one of the largest outpatient medical imaging providers in the United States, has ...

Time July 08, 2025
arrow
News | Image Guided Radiation Therapy (IGRT)

June 25, 2025 — Royal Philips and Indiana-based Methodist Hospitals recently announced the healthcare provider’s ...

Time June 25, 2025
arrow
News | PET-CT

June 23, 2025 — GE HealthCare’s commitment to advancing precision care in cardiology through its molecular imaging ...

Time June 23, 2025
arrow
Subscribe Now